WAM
TEVA icon

World Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

World Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,367
Closed -$93K – 878
2020
Q1 		$93K Hold
10,367
– – 0.01% 861
2019
Q4 		$102K Sell
10,367
-2,012
-16% -$18K ﹤0.01% 1051
2019
Q3 		$85K Sell
12,379
-2,345
-16% -$18K ﹤0.01% 1118
2019
Q2 		$136K Sell
14,724
-665
-4% -$8.02K 0.01% 1100
2019
Q1 		$241K Hold
15,389
– – 0.01% 956
2018
Q4 		$237K Sell
15,389
-10,486
-41% -$215K 0.01% 867
2018
Q3 		$557K Sell
25,875
-4,584
-15% -$106K 0.03% 659
2018
Q2 		$741K Sell
30,459
-9,959
-25% -$203K 0.04% 556
2018
Q1 		$691K Sell
40,418
-16,923
-30% -$330K 0.03% 616
2017
Q4 		$1.09M Sell
57,341
-2,244
-4% -$33.8K 0.04% 573
2017
Q3 		$1.05M Sell
59,585
-156
-0.3% -$3.51K 0.03% 592
2017
Q2 		$1.99M Sell
59,741
-3,449
-5% -$107K 0.07% 347
2017
Q1 		$2.03M Buy
63,190
+942
+2% +$32.1K 0.07% 361
2016
Q4 		$2.26M Sell
62,248
-5,563
-8% -$222K 0.09% 290
2016
Q3 		$3.12M Buy
67,811
+4,596
+7% +$240K 0.11% 223
2016
Q2 		$3.17M Buy
63,215
+4,886
+8% +$260K 0.12% 199
2016
Q1 		$3.12M Buy
58,329
+4,506
+8% +$264K 0.12% 198
2015
Q4 		$3.53M Buy
53,823
+4,120
+8% +$255K 0.13% 181
2015
Q3 		$2.81M Buy
49,703
+4,057
+9% +$263K 0.12% 218
2015
Q2 		$2.7M Sell
45,646
-2,906
-6% -$179K 0.11% 238
2015
Q1 		$3.02M Sell
48,552
-168
-0.3% -$9.77K 0.1% 232
2014
Q4 		$2.8M Sell
48,720
-327
-0.7% -$18.2K 0.1% 252
2014
Q3 		$2.64M Sell
49,047
-2,665
-5% -$141K 0.08% 290
2014
Q2 		$2.71M Buy
51,712
+4,186
+9% +$214K 0.08% 290
2014
Q1 		$2.51M Sell
47,526
-5,480
-10% -$253K 0.08% 304
2013
Q4 		$2.12M Sell
53,006
-17,626
-25% -$694K 0.06% 410
2013
Q3 		$2.67M Sell
70,632
-14,704
-17% -$574K 0.07% 363
2013
Q2 		$3.35M Buy
+85,336
New +$3.32M 0.08% 306

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

World Asset Management's TEVA Position: Q2 2020 in Review

World Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 10,367 shares — an estimated $93K sold.

World Asset Management first reported a position in TEVA in Q2 2013 and held it in 28 quarters. The position peaked at $3.53M in Q4 2015. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • World Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • World Asset Management sold 10,367 Teva Pharmaceuticals shares in Q2 2020, an estimated $93K.
  • World Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • World Asset Management's Teva Pharmaceuticals position peaked at $3.53M in Q4 2015.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on World Asset Management's 13F filing for Q2 2020, filed 24 Jul 2020.